搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
1 小时
Acurx为ibezapolstat的CDI三期临床试验做准备
STATEN ISLAND - Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) 公布了其抗生素候选药物ibezapolstat的有前景的研究结果,该药物正在为治疗艰难梭菌感染(CDI)的国际三期临床试验做准备。在国际艰难梭菌研讨会上展示的这些发现,展示了ibezapolstat与其分子靶标的独特相互作用,这可能使其与其他抗生素区别开来。 这项与莱顿大学医学中心 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Left note, bail denied
John becomes Category 3
Devils Tower climber dies
Seeks NIL compensation
Texas sues Biden admin
Calif. school phone ban law
Ammonia-powered tug sails
Asks to be put on NY ballot
Didn't authorize apology
1/3 think they have CTE
NY reports death from EEE
Returning Indian antiquities
Colo. shooter found guilty
UAE president WH meeting
Friedkin set to buy Everton
1951 kidnap victim found
Reds fire manager
Closing last full-size store
California sues ExxonMobil
Co-founder testifies
Visits US ammunition plant
FBI: Violent crime declined
NE electoral change blocked
More troops to Middle East
Gulf Coast storm warning
Bulls escape MA rodeo
SpaceX plans Mars missions
Astronauts return to Earth
Tech ban proposed
No govt. shutdown for now
反馈